Know Cancer

or
forgot password


N/A
18 Years
N/A
Open (Enrolling)
Both
Polycythemia Vera

Thank you

Trial Information


Inclusion Criteria:



- Polycythemia vera

- Treatment by therapeutic bleedings

- No cytotoxic treatment during the previous six months

Exclusion Criteria:

- No Polycythemia vera

- No treatment by therapeutic bleedings

- Cytotoxic treatment during the previous six months

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

To describe immunologic anomalies in polycythemia vera

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Regis Costello

Investigator Role:

Principal Investigator

Investigator Affiliation:

Assistance Publique Hopitaux De Marseille

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

2009/16

NCT ID:

NCT01284712

Start Date:

July 2009

Completion Date:

Related Keywords:

  • Polycythemia Vera
  • treatment by bleedings
  • Polycythemia
  • Polycythemia Vera

Name

Location